Hippocampal GFAP in aging: Associations with AD and LATE‐NC pathologies and cognitive decline in older adults
Alzheimer's & Dementia · 2026-06 · 22 (6)
DOI: 10.1002/alz.71613 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 17.06.2026. Verfasst von Sonal Agrawal und 10 weiteren Autor:innen. Beteiligte Einrichtung: Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Aging, Alzheimer Disease, Cognitive Dysfunction, Dementia. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, National Institute on Aging Grants.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
INTRODUCTION Plasma glial fibrillary acidic protein (GFAP) is an emerging biomarker for Alzheimer's disease (AD) progression in clinical studies, yet the role of brain GFAP in AD/AD‐related dementias (ADRD) pathologies and cognitive decline remains unclear. METHODS GFAP burden from CA1‐subiculum of the hippocampus were quantified. Regression and mixed‐effect models, adjusting for demographics and other brain pathologies examined associations between hippocampal GFAP and AD/ADRD pathologies and separately with Alzheimer's dementia and cognitive decline. RESULTS Limbic‐predominant age‐related TDP‐43 encephalopathy neuropathologic changes (LATE‐NC), hippocampal sclerosis of aging (HS‐A), and neurofibrillary tangle density (but not amyloid‐beta) were associated with GFAP burden. Hippocampal GFAP was associated with increased odds of Alzheimer's dementia and faster decline in global cognition, episodic memory, semantic memory, and perceptual speed. LATE‐NC and tangles explained some but not all the association between hippocampal GFAP and cognitive decline. DISCUSSION GFAP burden in the hippocampus is related to LATE‐NC and tangles but may also be an independent contributor to cognitive decline.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, USA.
- Department of Pathology, Rush University Medical Center, Chicago, Illinois, USA.
- Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA.
- Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois, USA.
- Department of Neurology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Förderung
- NIA NIH HHS
- National Institute on Aging Grants
Zitieren
APA
Agrawal, S., Yu, L., Leurgans, S. E., Li, J., Kapasi, A., Agarwal, P., Dage, J. L., Barnes, L. L., Bennett, D. A., Boyle, P., & Schneider, J. A. (2026). Hippocampal GFAP in aging: Associations with AD and LATE‐NC pathologies and cognitive decline in older adults. Alzheimer's & Dementia, 22(6). https://doi.org/10.1002/alz.71613
Vancouver
Agrawal S, Yu L, Leurgans SE, Li J, Kapasi A, Agarwal P, et al. Hippocampal GFAP in aging: Associations with AD and LATE‐NC pathologies and cognitive decline in older adults. Alzheimer's & Dementia. 2026;22(6). doi:10.1002/alz.71613
BibTeX
@article{Agrawal2026,
author = {Agrawal, Sonal and Yu, Lei and Leurgans, Sue E and Li, Jialiang and Kapasi, Alifiya and Agarwal, Puja and Dage, Jeffrey L and Barnes, Lisa L and Bennett, David A and Boyle, Patricia and Schneider, Julie A},
title = {Hippocampal GFAP in aging: Associations with AD and LATE‐NC pathologies and cognitive decline in older adults},
journal = {Alzheimer's & Dementia},
year = {2026},
volume = {22},
number = {6},
doi = {10.1002/alz.71613}
}
EUVIMED